According to Newswise, the Omar Boraie Chair in Genomic Science was established at Rutgers University.
Rutgers University now has a new academic chair, and it was named after the prominent real estate developer Omar Boraie. Boraie, who has had an interest in cancer research for many years, made a pledge of supporting the new chair with more than $1.5 million in order to enhance the field of precision medicine. The chair was too part of a program that consisted of other 17 academic chairs. According to Patch, the campaign program, however, would have not been possible without the help of an anonymous individual, who donated about $3 million to each chair.
Thanks to genomic sequencing and precision medicine, physicians have been able to analyze tumors on a genetic level. Thus, through genomic analysis, oncologists can prescribe tailored diagnoses and therapies. Precision medicine, though still quite a new field, has received a lot of attention on behalf of the scientific community. It was even recognized by the then President Barack Obama.
The business magnate, in this case, perhaps focused on Rutgers Cancer Institute because of its genuine concentration on genomic sequencing. For instance, the Cancer Institute of New Jersey was the first facility in its state to apply genomic sequencing as a precision medicine approach. Through genomic sequencing, oncologists, for example, have found better treatments for patients with rare types of cancers. Others have become immune to conventional treatments, and they have also benefited from genomic analysis.
According to Boraie, who also has a rigorous background in chemistry, the scientists and physicians from Rutgers Cancer Institute (http://magazine.rutgers.edu/insights/seeing-the-future) have contributed a lot to the field of precision medicine, and many cancer patients have benefited from their efforts. Boraie also hopes that he has influenced other affluent individuals. The business magnate, after all, was too influenced by the anonymous individual. Robert S. DiPaola, the current director of Rutgers Cancer Institute, thinks that Boraie’s contributions will leave a great legacy. Boraie’s actions will greatly impact cancer research.
The physician-scientist and professor of medicine Shridar Ganesan was nominated for the prestigious chair. According to Ganesan, Boraie’s pledge will bring new understandings in the field of cancer biology, and there will be new hope for cancer patients from all parts of the world. Ganesan also thinks that there is still a lot to learn about tumors. Cancer is rather a collection of diseases, and through genomic analysis, oncologists can create better classification systems.
To learn more about Omar, visit his crunchbase.com bio.
Litigation is a career in law that involves bringing forward a claim in the form of a lawsuit from the beginning to the end. It brings in the defendants and plaintiffs in a civil case. In litigation, a lot of legal paperwork is filed at the court once the lawsuit commences. The stages that litigation takes are pleading, examination, finding, pre-trial, trial, settlement, and appeal.
Litigator’s workdays are different depending on whether they are working as sole practitioners at a small or at a large firm. Litigators at big enterprises have different responsibilities based on their level of seniority. As a starter, a litigator does many pieces of research and writes memos. Such a litigator get exposure and is likely to argue or observe while sitting at the gallery. The lawyer may also get the opportunity to discuss in a small claim court or even deal with some clients and opposing attorney.
To become a successful litigator, one needs to have a bachelor’s degree and also attend the law school. In Philadelphia, there is a well-known litigator known as Karl Heideck. He is a highly regarded lawyer with a lot of experience in litigation, risk management, and compliance. At present, Karl Heideck works at Grant &Eisenhofer as a Counsel Contract attorney in compliance and risk management. Karl Heideck was working for Pepper Hamilton LLP as the project attorney for the period of between October 2010 and April 2014. He was a top-ranking quality control specialist.
Karl Heideck has also worked with Conrad O’Brien. He was an associate here and got the opportunity to represent corporate as well as individual clients in complex litigation. Karl Heideck schooled at Temple University, James E. Beasley School of Law. He has some skills that include employment law, civil litigation, mediation, commercial litigation, product liability, legal research, arbitration, legal writing, employment law, intellectual property among others.
InnovaCare Health, Inc., a leader in the provision of Medicare Advantage and Medicaid in Puerto Rico, recently made an announcement about three additions to its leadership team. Rick Shinto, its CEO, made the announcement according to hrmronline.com.
One of the additions, Jonathan Meyers, will take up the position of Chief Actuary Officer at the company. Before joining InnovaCare, he worked at Horizons BCBS as its Director of Actuarial Services, Medicare, and Medicaid. He has also worked in a similar position at HealthCare Partner in New York. Additionally, Jonathan has provided consultancy services on employee benefits to large Unions and employers. Some of his clients include SEIU 1199, Johnson & Johnson, and Northwell Health. His job was to provide advice to the senior executives on issues regarding healthcare benefits for retirees and employees.
The second addition to the team is Penelope Kokkinides. She will serve in the role of Chief Administrative Officer. Her experience in Medicare and Medicaid services, as well as the managed care sector, spans over two decades. Additionally, she is quite knowledgeable on the development of clinical programs.
Kokkinides has held various top executive positions in the past. At one time, she was the Executive VP and COO at Centerlight HealthCare. At the firm, she was responsible for all strategic direction and overall management of its managed care division. Kokkinides has also served as the COO at Touchstone Health and as a Corporate VP at AmeriChoice. Read more about her interview on Ideamensch
The third person to join the leadership team is Mike Sortino. He will take the position of the Chief Accounting Officer. Prior to this role, Mike worked at Samsung Fire & Marine Insurance Co., Ltd (US) as the Controller. Before joining Samsung, he was the Chief Finance Officer at HCC Specialty for five years. He has about five years of experience in public accounts and has worked in the reinsurance and insurance sectors for over two decades.
InnovaCare Signs Up for an Initiative to Reform Payment Models
Officials at the company announced that InnovaCare Health, Inc., would sign up for the Heath Care Payment Learning and Action Network (LAN). This initiative is a public-private partnership that seeks to move towards a payment model based on quality, not quantity.
About InnovaCare Health, Inc.
As a top provider of managed healthcare services, InnovaCare Health has grown into a reliable healthcare partner not only in Puerto Rico but also in North America. The company also manages two Medicaid plans within the Government Health Plan of Puerto Rico. Today, it is the only provider of NCQA-accredited health plans on the island.
Jeanmarie Guenot has been a leader in the pharmaceutical industry for over 20 years. She has held various positions in the biotechnology and pharmaceutical industry. She has worked with both private and public corporations in areas of business development, project and alliance management, venture capital, and research and development. She is well versed in the process of rebuilding and building corporations. Jeanmarie currently holds the position of CEO at Amphivena Therapeutics, Inc. The company is mainly focused on the area of bifunctional antibody therapies to aid with hematologic malignancies.
Before she took on her current position, she was running a startup known as SKS Ocular. The ophthalmic company incubator was focused on glaucoma therapeutics, ocular drug delivery technology, ocular inflammation, macular degeneration, and dry AMD. She had also held the position of VP in charge of Corporate & Business Development at PDL BioPharma. At the company, she was in charge of mergers and acquisitions, licensing, and alliance management for R&D.
During her time there she led a co-development program between PDL and Biogen Idec which involved three candidates with Phase 2 cancer. The transaction, which was worth $800 million, involved a $100 million investment in PDL. During her time at PDL, she also helped to negotiate the licensing of ophthalmic indication for an oncology drug to Ophthotech. Jeanmarie Guenot has vast experience in the areas of cardiovascular diseases, neurology, autoimmune diseases, and neurology.
LinkedIn.com shows that Jeanmarie Guenot started her successful career at Atlas Venture. She was in charge of managing venture capital investments. She also helped to build a number of life science companies. Her scientific career began when she joined Preclinical R&D at Hoffmann- La Roche. Her job entailed the discovery and development of drugs for inflammation, autoimmune illnesses, oncology, and metabolic disorders. She trained in medical and physical chemistry. Her area of focus was semi-empirical methods for molecular dynamics, X-ray, drug design, and NMR refinement. Dr. Guenot earned her Ph.D. from the University of California. Her MBA was earned from the Wharton school of finance of the University of Pennsylvania.
Jeanmarie has a lot of experience in the management of large companies. Her commitment to professionalism, integrity and hard work ensure that will continue to enjoy lots of success in coming years. Learn more about Jeanmarie Guenot from her Facebook page, or her bio page of the Guenot LLC website.
USHEALTH Group, Inc. is an insurance company that is based in Fort Worth, Texas. The company focuses on the provision of innovative health coverage for persons that are self-employed and good owners of small businesses. The company aspires to be the America’s trusted choice for healthcare. In basic terms, USHEALTH Group has a family of enterprises and together give specified sickness, accidents as well as disability insurances to its customers.
USHEALTH Group has been pleased to serve over 15 million customers with plans for over 50 years collectively. The group has achieved all these through its insurance companies. The products that the company offers are worthwhile. Regarding diseases that are specified and accident coverage, USHEALTH Group family of enterprises acknowledges the existence of different needs for every customer.
The company in a great way believe in choice and that the client value the variety of options that are provided because they choose the most appropriate protection. The company has thus developed a portfolio of coverages that encourage customer choice. The products in their nature are designed to ensure the USHEALTH Group family of businesses qualify to tackle the needs of each client uniquely.
The company offers a portfolio of creative products that give first dollar welfare for covered services and a considerable network discount, for those clients that either has a limited budget or have a concern over satisfying a high yearly deductible prior they receive any advantage from the insurance plan.
Supposing that a client wants the security of a more simple coverage approach and can afford the cost sharing, USHEALTH Group family of companies gives welcome solutions that are reliable, flexible, and affordable through the different section that is specified for sickness and accident plan.
For any health coverage that the clients choose, the company gladly help its customers boost their protection with its full line of additional products that include specified disease, accidents, critical illness, income protector, dental plans, short term accident disability income, vision plans as well as term life insurance.
USHEALTH Group family of companies differentiates itself from other businesses in the market by creating relationships with clients that are long-term.
The Copa Star Hospital is a state-of-the-art medical institution that provides excellent service to its clients. The high-end facility is controlled by the D’Or network, which current own 22 top-notch hospitals in Brazil. The organization has established excellent medical infrastructures that are located in different parts of the country. According to the proprietor of the D’Or network, Jorge Molly, the foundation has created the first five-star hospital in Rio de Janeiro. Most people in the region did believe that a first class facility with luxurious accommodation can be set up there. The D’Or network plans to expand in future by building more first-class hospitals in areas such as Sao Paulo.
The topnotch hospital has been designed to provide the best medical attention, hospitality, and comfort to the patients. It has experienced doctors and nurses and applies the latest technology in offering services. Copa Star is keen on hiring the best medical professionals, and it has been using exceptional techniques to ensure that it gets exceptional talents. The hospitality and environment that the hospital offers enable it to attract any patients. It also ensures that the privacy of its patients is maintained hence public figures can be served without interruption due to their status. Brazilians and people from other parts of the world seeking high-end medical attention can be comfortable at the Copa Star Hospital. Visit their page on Facebook.
The top priority of the Copa Star Hospital is to ensure the recovery of the patients. The luxury amenities are secondary. The hospital has innovative machinery that is used in the treatment of cardiac and neurological problems. It has also established 59 ICU wards that are advanced and allow the patients to interact with the outside world through video conferencing technology. Copa Star is currently served by over 500 experts who have been trained to provide exceptional services to the clients. The nurses are also coached to tackle particular situations that affect the hospital’s patients.
Copa Star also has modern MRI machines that have been installed at its diagnostic center. Its neurosurgery wards have ultramodern equipment for addressing emergencies and highly complicated situations. It has high-tech robots, operating rooms, and surgeons who have adequate skill to offer the best medical care. Patients can also manage their surrounding, which includes the temperature, curtains, and doors by using software that is installed on their iPads. They can also contact the doctors via the iPads. Read more about the hospital at rafarquitetura.com.
Mikhail Blagosklonny is a distinguished scientist who focuses on the study of cancer and the process of aging. He is also a renowned professor of oncology at Roswell Park Cancer Institute located in New York. Mikhail has a solid educational background having attended the First Pavlov State Medical University of St. Petersburg. He attained a Ph.D. in cardiology and experimental medicine from the University and in the year 2002, he got appointed the associate professor of medicine at New York Medical College. This was before taking a position as a senior scientist in Ordway Research Institute located in Albany; he held this post for some time before he was appointed the professor of oncology at Roswell Park Cancer Institute.
Mikhail specializes in understanding the fundamental mechanisms of aging, cancer research and therapies that aim to protect healthy cells from further damage, and formulation of anti-aging elixirs. He is well known for formulating a hypothesis on the probable function of TOR signaling in handling cancer and aging. Mikhail Blagosklonny is also known for his enthusiasm towards the use of rapamycin to extend life. Rapamycin is a common drug used in curing of cancer. As a matter of facts, Mikhail is Blagosklonny a major advocate for rapamycin in prolonged existence research who is known globally for his passion.
Mikhail is also reputed for his numerous publications. He has authored more than 250 papers and has got almost 30,000 citations. He writes on topics he has researched on over the years and are inclusive of signal transduction, Molecular biology, tumor suppressors as well as oncogenes. One of the most popular papers by Mikhail is the one on the role of TOR Signaling in anti-aging. He has adopted unique research strategies that have seen him be ranked among the top most researchers on aging therapeutics and cancer.
Mikhail Blagosklonny is also known for his role as the editor-in-chief of Oncotarget. This is a peer-reviewed medical journal that is weekly and covers research on all aspects of oncology. This journal is published by Impact Journals and was established in 2010. He is also the editor-in-chief of other journals which include Aging and Cell cycle. View his LinkedIn profile to know more about Mikhail.
George Soros is a famous billionaire who has been recognized among the most successful investors in the world. The business magnate is also reputed for his remarkable contribution towards charitable causes as well as his selfless political funding. The popular Democrat who had cut down on his political giving since he lost the bid to oust President George Bush, is now back in the political scenes. George Soros gave around 27 million dollars to try defeat President Bush. In the recent election, George is said to have given out more than 25 million us dollars in a bid to boost Clinton and other Democratic candidates as well as causes.
Soros felt that the Republicans had fueled an intense anti-Muslim and anti-immigrant rhetoric that was deeply offensive. However, just like everyone else, Soros was surprised by Trump’s shocking victory over Clinton. This led to George Soros and other wealthy liberals on Snopes to gather for a three-day summit which was a closed-doors meeting to retool the money left to fight back against Donald Trump.
Looking at the agenda of the summit, the Liberals plan a full-on trench war against Trump. Some of the sessions in the meeting focused on frustrating Trump’s 100-day plan on nytimes.com. According to the agenda, the plan was termed as an assault on President Obama’s achievements and the progressive vision for a just and an equitable nation.
The president of the Democracy Alliance, Gara LaMarche sent donors emails informing them that the D.C meeting will look at the steps that ought to be taken together to resist the attacks that they were receiving and to get back power. According to a strategist on opensocietyfoundations.org, the Democracy Alliance should, however, be called into question. It looks to the strategist like the alliance had been reduced to a mere social club for a bunch of wealthy white donors and labor union heads to read memos and drink wine as the Democratic Party crumbles around them. The Democratic Alliance is an organization that was founded by George Soros and other wealthy liberals in 2004 after they lost their bid to oust George Bush.
This alliance has a network of progressive donors responsible for coordinating the political donations to groups endorsed by the Alliance. Last year Soros came out strongly in the campaigns against Trump. George Soros allegedly donated seven million dollars to Priorities USA Action. He also gave Hillary Clinton the maximum 2,700 dollars donation and a five million to a PAC aimed at mobilizing Latinos and other immigrants in a bid to stop the Trump campaigns.
Soros has had a stellar track recording when it comes to the funding of liberal political causes. The individual who is ranked 23rd on Forbes richest men list is also known for his philanthropy. As a member of the Giving Pledge, he has pledged more than half of his worth to go to charity. Soros had gone silent in the political scene for over ten years. He, however, seems to be back with even more vigor. He has hit the headlines severally since the last elections between Hillary Clinton and Donald Trump.
The challenges that companies in the healthcare industry experience span from competition to the harsh environment in which they have to operate in. To have a working system that guarantees the achievement of the goals one has put in place, it is necessary to consult with professionals, who can then design a service delivery structure that is made to work in sync with the many provisions that are put in place to help the company grow. Although every company faces its share of challenges, most of them can be countered through effective leadership and developed structures.
At the onset of its operations, InnovaCare Health had little support from individuals who could interpret problems to offer solutions to the many problems the company encounters. Its growth structure has been a path of development that has seen the company emerge from a struggling platform to become the current leader in managed healthcare services across Puerto Rico. InnovaCare Health, through the leadership of Rick Shinto, has been in the forefront championing for the development of high quality products and the delivery of services that add value to the needs of the user, reason it managed to grow so fast between 2012 and today.
Having built his career over 20 years, Rick Shinto enjoys the possession of unique skills that allow him to offer guidance and leadership that is focused and directed towards reviving the development of InnovaCare Health. He has served at different successful companies including Aveta Inc and MedPartners. His massive knowledge and skills in clinical medicine were an inspiration that allowed him to draft unique journals and articles detailing his support for methods of dealing with problems in the healthcare industry.
About Penelope Kokkinides
Penelope Kokkinides has been serving at InnovaCare Health, offering support to the top leadership to ensure the company embraces ideas that are progressive and designed to offer growth and development. She oversaw the process that led to the design of a modern system of dealing with service delivery and most of her ideas helped to install a working environment for InnovaCare Health.
About InnovaCare Health
InnovaCare Health has grown over the years to rank as one of the most established companies in the provision of managed healthcare services across Puerto Rico. It has been operational for over 10 years, developing a strong platform for the Medicare Advantage plans users, who benefit from unique and beneficial products from the company.
Securus Technologies is a Dallas, Texas company that provides broad-based communications to correctional institutions, law enforcement facilities, and safety organizations in all of North America. At present, Securus serves over 3,400 institutions and over 1.2 million inmates and their families.
The technology used by Securus allows connectivity to all Android and Apple devices such as smartphones, iPads, tablets and regular landline phones. In addition to regular voice service, Securus allows transmission by video, email, text, and a money transfer system.
Securus recently was honored to receive an A+ rating from the Better Business Bureau of Texas. This is the highest rating that any company can receive, and it is awarded for high levels of service and commitment to their customers. Not every business qualifies for the designation, as there are a rigorous background evaluation and application process. However, after a very detailed examination, Securus was accredited with the award.
Securus has in place a 220 seat phone room that handles 2.5 million calls per month. They have an average answer time of 11 seconds, a first call resolution of 99%, and a customer satisfaction rate of 4.3 out of 5 points. These are remarkable statistics when the large volume of calls are considered.
By having the Better Business Bureau award, the distinguished A+ rating says that an independent agency upholds the high standards of customer service are real and are based on actual results rather than hyperbole. A customer service team of over 1,300 associates are well-trained and dedicated to the maintenance of these results.
Securus believes in a theme of accountability and integrity when it comes to the maintenance of these figures and results. Rather than rely on exaggerations and suppositions, Securus takes their role seriously, and the plan for the future will be a continuation of the present levels of concern and service to customers.